Saol Therapeutics is committed to maintaining continuity of supply of all products during the COVID-19 pandemic.
We see patients as people, not statistics.
At Saol Therapeutics, patients with diseases who are underserved for whatever reason are so much more than statistics. They are patients who deserve a chance at improved health. They are patients who need to be heard and who need to be helped. These patient populations with unmet needs are the reason we are passionately committed to bringing therapies for serious and often life-threatening diseases and conditions to healthcare providers.
In addition to our focus on diseases that are sometimes categorized as rare, we have a specific expertise and interest in helping address conditions affecting the Central Nervous System (CNS). It is estimated that one in six people in the world suffer from some type of neurological condition – ranging from the common headache to conditions that may not be fully understood by the medical community– and we are here to help.
There are an estimated 1.5 billion people effected with rare diseases or neurological conditions. We recognize the challenges are significant, but the need is undoubtedly greater.
This is why Saol Therapeutics exists.
With patients, their disease is personal.
Every patient needs understanding and deserves care. Patients with rare diseases may feel forgotten, often with limited or no treatment options. Because of the complexity of CNS conditions, patients may spend years searching for a cause to their ailments, then, once discovered, hoping that a treatment exists. At Saol Therapeutics, our focus on providing therapies for these underserved patient populations allows us to impact lives in a significant and measurable way.
We welcome strategic partnerships with pharmaceutical and biopharma companies.Partner with us
Get the latest news and find out where to find Saol at upcoming medical conferences.Find out now
MAKE A DIFFERENCE
Patients are more than statistics at Saol – and so are our employees.Join our team